GIANNOULIA, PANAGIOTA
 Distribuzione geografica
Continente #
NA - Nord America 276
EU - Europa 262
AS - Asia 91
AF - Africa 25
OC - Oceania 1
SA - Sud America 1
Totale 656
Nazione #
US - Stati Uniti d'America 276
GB - Regno Unito 74
SE - Svezia 54
VN - Vietnam 32
IT - Italia 30
CN - Cina 23
DE - Germania 23
IE - Irlanda 16
CH - Svizzera 14
IN - India 14
TG - Togo 12
RU - Federazione Russa 11
FR - Francia 9
SG - Singapore 9
EE - Estonia 8
BG - Bulgaria 7
CI - Costa d'Avorio 7
JO - Giordania 7
UA - Ucraina 7
ZA - Sudafrica 5
IR - Iran 4
GR - Grecia 3
BE - Belgio 2
FI - Finlandia 2
MY - Malesia 2
CL - Cile 1
NL - Olanda 1
NZ - Nuova Zelanda 1
RO - Romania 1
SC - Seychelles 1
Totale 656
Città #
Southend 73
Chandler 65
Dong Ket 32
Fairfield 20
Dublin 16
Wilmington 16
Houston 14
Princeton 14
Seattle 14
Bern 13
Cambridge 12
Lomé 12
Woodbridge 11
Ashburn 10
New York 10
Singapore 8
Abidjan 7
Amman 7
Padova 7
Sofia 7
Turin 7
Westminster 7
Ann Arbor 6
Jacksonville 6
Medford 5
Nanjing 4
Saint Petersburg 4
Tianjin 4
Hebei 3
Olalla 3
Redwood City 3
Rome 3
Beijing 2
Bremen 2
Brussels 2
Changsha 2
Florence 2
Helsinki 2
Kish 2
Milan 2
Rawang 2
Shenyang 2
Andover 1
Auckland 1
Falls Church 1
Fuzhou 1
Groningen 1
Henderson 1
Jinan 1
Kunming 1
La Canada Flintridge 1
Lausanne 1
Leawood 1
Mahé 1
Moscow 1
Orange 1
Parma 1
San Diego 1
San Mateo 1
Suceava 1
Wenzhou 1
Zanjan 1
Totale 463
Nome #
The Bcr-Abl kinase promotes aberrant expression of spliced oncogenic Ikaros isoforms in Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL) patients treated with tyrosine kinase inhibitors 117
Presence or the Emergence of a F317L BCR-ABL Mutation May Be Associated With Resistance to Dasatinib in Philadelphia Chromosome Positive Leukemia 112
null 104
Innovative phase I-II study of concomitant and consecutive treatment with Dasatinib and MK-0457 in refractory Ph+ CML and ALL patients 85
High-resolution genomic profiling of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) patients identified novel recurrent copy number variations involved in both pathogenesis and resistance to tyrosine kinase inhibitors 76
New drugs to overcome meccanisms of resistance in Ph+ leukemia: Bosutinib 74
Genome wide analysis of Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) reveals a recurring deletion of VPREB1 gene which affects B-cell differentiation 68
Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain 41
Totale 677
Categoria #
all - tutte 1.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.499


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020125 29 3 1 10 8 9 13 20 14 6 8 4
2020/202180 17 3 0 1 1 6 0 2 5 3 1 41
2021/2022143 6 7 7 19 10 9 4 10 3 12 29 27
2022/2023208 22 40 7 27 13 14 4 9 34 3 20 15
2023/202443 1 6 2 6 4 18 0 0 0 1 1 4
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 677